Have a personal or library account? Click to login
Sepsis and the muscle tissue. A narrative review Cover
Open Access
|Aug 2021

References

  1. 1. BORGES RC, CARVALHO CRF, COLOMBO AS, DA SILVA BORGES MP, SORIANO FG. Physical activity, muscle strength, and exercise capacity 3 months after severe sepsis and septic shock. Intensive Care Med. 2015;41(8):1433–1444.10.1007/s00134-015-3914-y26109398
  2. 2. CALLAHAN LA, SUPINSKI GS. Sepsis-induced myopathy. Crit Care Med. 2009;37(10 Suppl):S354-S367.10.1097/CCM.0b013e3181b6e439396751520046121
  3. 3. LATRONICO N, GOSSELINK R. A guided approach to diagnose severe muscle weakness in the intensive care unit. Rev Bras Ter intensiva. 2015;27(3):199–201.10.5935/0103-507X.20150036459211126376161
  4. 4. HERMANS G, VAN MECHELEN H, CLERCKX B, et al. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2014;190(4):410–420.10.1164/rccm.201312-2257OC24825371
  5. 5. SHEPHERD S, BATRA A, LERNER DP. Review of Critical Illness Myopathy and Neuropathy. The Neurohospitalist. 2017;7(1):41–48.10.1177/1941874416663279516709328042370
  6. 6. BOLTON CF, LAVERTY DA, BROWN JD, WITT NJ, HAHN AF, SIBBALD WJ. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1986;49(5):563–573.10.1136/jnnp.49.5.56310288113011996
  7. 7. MACFARLANE IA, ROSENTHAL FD. Severe myopathy after status asthmaticus. Lancet (London, England). 1977;2(8038):615.
  8. 8. De Jonghe B, Lacherade J-C, Sharshar T, Outin H. Intensive care unit-acquired weakness: risk factors and prevention. Crit Care Med. 2009;37(10 Suppl):S309–15.10.1097/CCM.0b013e3181b6e64c20046115
  9. 9. BOLTON CF. Neuromuscular manifestations of critical illness. Muscle Nerve. 2005;32(2):140–163.10.1002/mus.2030415825186
  10. 10. BIRD SJ. Diagnosis and management of critical illness polyneuropathy and critical illness myopathy. Curr Treat Options Neurol. 2007;9(2):85–92.10.1007/s11940-007-0034-117298769
  11. 11. WEBER-CARSTENS S, DEJA M, KOCH S, et al. Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care. 2010;14(3):R119.10.1186/cc9074291176720565863
  12. 12. FRIEDRICH O, REID MB, VAN DEN BERGHE G, et al. The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill. Physiol Rev. 2015;95(3):1025–1109.10.1152/physrev.00028.2014
  13. 13. QIU Y, JIANG L, XI X. [Early incidence and prognosis of ICU-acquired weakness in mechanical ventilation patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019;31(7):821–826.
  14. 14. LATRONICO N, BOLTON CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10(10):931–941.10.1016/S1474-4422(11)70178-8
  15. 15. VANHOREBEEK I, LATRONICO N, VAN DEN BERGHE G. ICU-acquired weakness. Intensive Care Med. 2020;46(4):637–653.10.1007/s00134-020-05944-4
  16. 16. DAMIAN MS, WIJDICKS EFM. The clinical management of neuromuscular disorders in intensive care. Neuromuscul Disord. 2019;29(2):85–96.10.1016/j.nmd.2018.12.005
  17. 17. BOUGLÉ A, ROCHETEAU P, SHARSHAR T, CHRÉTIEN F. Muscle regeneration after sepsis. Crit Care. 2016;20(1):131.10.1186/s13054-016-1308-3
  18. 18. LANONE S, MEBAZAA A, HEYMES C, et al. Muscular contractile failure in septic patients: role of the inducible nitric oxide synthase pathway. Am J Respir Crit Care Med. 2000;162(6):2308–2315.10.1164/ajrccm.162.6.2001097
  19. 19. HOTCHKISS RS, STRASSER A, MCDUNN JE, SWANSON PE. Cell death. N Engl J Med. 2009;361(16):1570–1583.10.1056/NEJMra0901217
  20. 20. MAESTRAGGI Q, LEBAS B, CLERE-JEHL R, et al. Skeletal Muscle and Lymphocyte Mitochondrial Dysfunctions in Septic Shock Trigger ICU-Acquired Weakness and Sepsis-Induced Immunoparalysis. Biomed Res Int. 2017;2017:7897325.10.1155/2017/7897325
  21. 21. BREALEY D, BRAND M, HARGREAVES I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet (London, England). 2002;360(9328):219–223.10.1016/S0140-6736(02)09459-X
  22. 22. PASCUAL-GUARDIA S, ÁRBOL F, SÁNCHEZ E, et al. [Inflammation and oxidative stress in respiratory and limb muscles of patients with severe sepsis]. Med Clin (Barc). 2013;141(5):194–200.10.1016/j.medcli.2012.05.02622841463
  23. 23. KLAUDE M, MORI M, TJÄDER I, GUSTAFSSON T, WERNERMAN J, ROOYACKERS O. Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis. Clin Sci (Lond).
  24. 24. LAGHI F, TOBIN MJ. Disorders of the respiratory muscles. Am J Respir Crit Care Med. 2003;168(1):10–48.10.1164/rccm.220602012826594
  25. 25. JAGOE RT, GOLDBERG AL. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care. 2001;4(3).10.1097/00075197-200105000-0000311517350
  26. 26. VAN HEES HWH, SCHELLEKENS W-JM, LINKELS M, et al. Plasma from septic shock patients induces loss of muscle protein. Crit Care. 2011;15(5):R233–R233.10.1186/cc10475333478121958504
  27. 27. FRIEDRICH O. Critical illness myopathy: sepsis-mediated failure of the peripheral nervous system. Eur J Anaesthesiol | EJA. 2008;25.10.1017/S026502150700326218289421
  28. 28. LACOMIS D. Neuromuscular disorders in critically ill patients: review and update. J Clin Neuromuscul Dis. 2011;12(4):197–218.10.1097/CND.0b013e3181b5e14d22361518
  29. 29. PATERNOSTRO-SLUGA T, GRIM-STIEGER M, POSCH M, et al. Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med. 2008;40(8):665–671.10.2340/16501977-023519020701
  30. 30. ALI NA, O’BRIEN JMJ, HOFFMANN SP, et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med. 2008;178(3):261–268.10.1164/rccm.200712-1829OC18511703
  31. 31. LATRONICO N, NATTINO G, GUARNERI B, et al. Validation of the peroneal nerve test to diagnose critical illness polyneuropathy and myopathy in the intensive care unit: the multicentre Italian CRIMYNE-2 diagnostic accuracy study. F1000Research. 2014;3:127.10.12688/f1000research.3933.1
  32. 32. KHAN J, HARRISON TB, RICH MM, MOSS M. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology. 2006;67(8):1421–1425.10.1212/01.wnl.0000239826.63523.8e17060568
  33. 33. LEFAUCHEUR J-P, NORDINE T, RODRIGUEZ P, BROCHARD L. Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatry. 2006;77(4):500–506.10.1136/jnnp.2005.070813207751716306155
  34. 34. Z’GRAGGEN WJ, BRANDER L, TUCHSCHERER D, SCHEIDEGGER O, TAKALA J, BOSTOCK H. Muscle membrane dysfunction in critical illness myopathy assessed by velocity recovery cycles. Clin Neurophysiol Off J Int Fed Clin Neurophysiol. 2011;122(4):834–841.10.1016/j.clinph.2010.09.02421044861
  35. 35. CRONE C. Tetraparetic critically ill patients show electrophysiological signs of myopathy. Muscle Nerve. 2017;56(3):433–440.10.1002/mus.2552527997678
  36. 36. RAGHIG H, BRYAN YOUNG G, HAMMOND R, NICOLLE M. A Comparison of EMG and Muscle Biopsy in ICU Weakness. Neurocrit Care. 2010;13(3):326–330.10.1007/s12028-010-9431-520717748
  37. 37. LARSSON L, LI X, EDSTRÖM L, et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med. 2000;28(1):34–45.10.1097/00003246-200001000-0000610667496
  38. 38. KERBAUL F, BROUSSE M, COLLART F, et al. Combination of histopathological and electromyographic patterns can help to evaluate functional outcome of critical ill patients with neuromuscular weakness syndromes. Crit Care. 2004;8(6):R358–R366.10.1186/cc2925106504915566579
  39. 39. HADDA V, KUMAR R, KHILNANI GC, et al. Trends of loss of peripheral muscle thickness on ultrasonography and its relationship with outcomes among patients with sepsis. J intensive care. 2018;6:81.10.1186/s40560-018-0350-4629201330564367
  40. 40. BORGES RC, SORIANO FG. Association Between Muscle Wasting and Muscle Strength in Patients Who Developed Severe Sepsis and Septic Shock. Shock. 2019;51(3):312–320.10.1097/SHK.000000000000118329757913
  41. 41. PUTHUCHEARY ZA, RAWAL J, MCPHAIL M, et al. Acute Skeletal Muscle Wasting in Critical Illness. JAMA. 2013;310(15):1591–1600.10.1001/jama.2013.27848124108501
  42. 42. GRIMM A, TESCHNER U, PORZELIUS C, et al. Muscle ultrasound for early assessment of critical illness neuromyopathy in severe sepsis. Crit Care. 2013;17(5):R227–R227.10.1186/cc13050405741324499688
  43. 43. PUTHUCHEARY ZA, PHADKE R, RAWAL J, et al. Qualitative Ultrasound in Acute Critical Illness Muscle Wasting. Crit Care Med. 2015;43(8):1603–1611.10.1097/CCM.000000000000101625882765
  44. 44. DEMOULE A, JUNG B, PRODANOVIC H, et al. Diaphragm dysfunction on admission to the intensive care unit. Prevalence, risk factors, and prognostic impact-a prospective study. Am J Respir Crit Care Med. 2013;188(2):213–219.10.1164/rccm.201209-1668OC23641946
  45. 45. SCHREIBER A, BERTONI M, GOLIGHER EC. Avoiding Respiratory and Peripheral Muscle Injury During Mechanical Ventilation: Diaphragm-Protective Ventilation and Early Mobilization. Crit Care Clin. 2018;34(3):357–381.10.1016/j.ccc.2018.03.00529907270
  46. 46. PETROF BJ. Diaphragmatic dysfunction in the intensive care unit: caught in the cross-fire between sepsis and mechanical ventilation. Crit Care. 2013;17(4):R181–R181.10.1186/cc12864405599923981865
  47. 47. LU Z, GE H, XU L, GUO F, ZHANG G, WU Y. Alterations in diaphragmatic function assessed by ultrasonography in mechanically ventilated patients with sepsis. J Clin Ultrasound. 2019;47(4):206–211.10.1002/jcu.2269030671990
  48. 48. LU ZH, GUO F, ZHANG G, GE HQ, XU LL, CHEN YL. [A clinical study of diaphragmatic dysfunction in subjects with mechanical ventilation in sepsis]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese J Tuberc Respir Dis. 2018;41(9):696–700.
  49. 49. JUNG B, NOUGARET S, CONSEIL M, et al. Sepsis Is Associated with a Preferential Diaphragmatic Atrophy: A Critically Ill Patient Study Using Tridimensional Computed Tomography. Anesthesiology. 2014;120(5):1182–1191.10.1097/ALN.000000000000020124608360
  50. 50. BALDWIN CE, BERSTEN AD. Alterations in Respiratory and Limb Muscle Strength and Size in Patients With Sepsis Who Are Mechanically Ventilated. Phys Ther. 2014;94(1):68–82.10.2522/ptj.2013004824009347
  51. 51. VIVIER E, ROUSSEY A, DOROSZEWSKI F, et al. Atrophy of Diaphragm and Pectoral Muscles in Critically Ill Patients. Anesthesiology. 2019;131(3):569–579.10.1097/ALN.000000000000273731094757
  52. 52. GOLIGHER EC, DRES M, FAN E, et al. Mechanical Ventilation-induced Diaphragm Atrophy Strongly Impacts Clinical Outcomes. Am J Respir Crit Care Med. 2018;197(2):204–213.10.1164/rccm.201703-0536OC28930478
DOI: https://doi.org/10.2478/rjim-2021-0005 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 218 - 226
Submitted on: Dec 5, 2020
|
Published on: Aug 26, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Eleousa Oikonomou, Themistoklis Paraskevas, Dimitris Velissaris, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.